ClinicalTrials.Veeva

Menu
N

NRC Research Institute | Los Angeles, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Olezarsen
Semaglutide
LB-102
ENX-102

Parent organization

This site is a part of NRC Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 4 total trials

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. (Illuminate1)

Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollment will be randomized (like f...

Enrolling
Bipolar I Disorder
Other: Placebo
Drug: LB-102

Trial sponsors

E
Ionis Pharmaceuticals logo
L
Novo Nordisk logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems